Specific use of start codons and cellular localization of splice variants of human phosphodiesterase 9A gene

BMC Molecular Biology

Volumn 7, Issue , 2006, Pages

  Rentero, Carles ^a,b   Puigdomènech, Pere ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLIC GMP PHOSPHODIESTERASE; GLYCINE; GREEN FLUORESCENT PROTEIN; PHOSPHODIESTERASE 9A; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CELL MEMBRANE; CELL VACUOLE; CELLULAR DISTRIBUTION; CODON USAGE; CONTROLLED STUDY; GENETIC CODE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN VARIANT; RNA SPLICING; START CODON;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CODON, INITIATOR; COS CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE ORDER; GOLGI APPARATUS; HELA CELLS; HUMANS; ISOENZYMES; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33751227839     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-7-39     Document Type: Article

References (34)

1. Soderling SH, Beavo JA: Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 2000, 12(2):174-179.
2. Francis SH, Turko IV, Corbin JD: Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 2001, 65:1-52.
3. Lugnier C: Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 2006, 109(3):366-398.
4. Rentero C, Monfort A, Puigdomenech P: Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene. Biochem Biophys Res Commun 2003, 301(3):686-692.
5. Guipponi M, Scott HS, Kudoh J, Kawasaki K, Shibuya K, Shintani A, Asakawa S, Chen H, Lalioti MD, Rossier C, Minoshima S, Shimizu N, Antonarakis SE: Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence. Hum Genet 1998, 103(4):386-392.
6. Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB: Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 1998, 273(25):15559-15564.
7. Andreeva SG, Dikkes P, Epstein PM, Rosenberg PA: Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci 2001, 21(22):9068-9076.
8. van Staveren WC, Glick J, Markerink-van Ittersum M, Shimizu M, Beavo JA, Steinbusch HW, de Vente J: Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain. J Neurocytol 2002, 31 (8-9):729-741.
9. van Staveren WC, Steinbusch HW, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, Beavo JA, De Vente J: mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 2003, 467(4):566-580.
10. Wunder F, Tersteegen A, Rebmann A, Erb C, Fahrig T, Hendrix M: Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line. Mol Pharmacol 2005, 68(6):1775-1781.
11. Bingham J, Sudarsanam S, Srinivasan S: Profiling human phosphodiesterase genes and splice isoforms. Biochem Biophys Res Commun 2006, 350(1):25-32.
12. Wang P, Wu P, Egan RW, Billah MM: Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution. Gene 2001, 280(1-2):183-194.
13. Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay MD: Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem J 1997, 328 (Pt 2):539-548.
14. Sasaki T, Kotera J, Omori K: Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Biochem J 2002, 361(Pt 2):211-220.
15. Blencowe BJ: Alternative splicing: new insights from global analyses. Cell 2006, 126(1):37-47.
16. Houslay MD, Milligan G: Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci 1997, 22(6):217-224.
17. Houslay MD, Sullivan M, Bolger GB: The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions. Adv Pharmacol 1998, 44:225-342.
18. Rubin CS: A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta 1994, 1224(3):467-479.
19. Jin SL, Bushnik T, Lan L, Conti M: Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. Differential targeting and activation of the splicing variants derived from the PDE4D gene. J Biol Chem 1998, 273(31):19672-19678.
20. Huston E, Pooley L, Julien P, Scotland G, McPhee I, Sullivan M, Bolger G, Houslay MD: The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J Biol Chem 1996, 271(49):31334-31344.
21. Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB: The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J Biol Chem 1999, 274(21):14909-14917.
22. McPhee I, Yarwood SJ, Scotland G, Huston E, Beard MB, Ross AH, Houslay ES, Houslay MD: Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition. J Biol Chem 1999, 274(17):11796-11810.
23. Grens A, Scheffler IE: The 5′- and 3′-untranslated regions of ornithine decarboxylase mRNA affect the translational efficiency. J Biol Chem 1990, 265(20):11810-11816.
24. Kozak M: Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 2005, 361:13-37.
25. Bonnal S, Schaeffer C, Creancier L, Clamens S, Moine H, Prats AC, Vagner S: A single internal ribosome entry site containing a G quartet RNA structure drives fibroblast growth factor 2 gene expression at four alternative translation initiation codons. J Biol Chem 2003, 278(41):39330-39336.
26. Komar AA, Hatzoglou M: Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J Biol Chem 2005, 280(25):23425-23428.
27. Huston E, Beard M, McCallum F, Pyne NJ, Vandenabeele P, Scotland G, Houslay MD: The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. J Biol Chem 2000, 275(36):28063-28074.
28. Pooley L, Shakur Y, Rena G, Houslay MD: Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines. Biochem J 1997, 321 (Pt 1):177-185.
29. Shakur Y, Takeda K, Kenan Y, Yu ZX, Rena G, Brandt D, Houslay MD, Degerman E, Ferrans VJ, Manganiello VC: Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum. J Biol Chem 2000, 275(49):38749-38761.
30. Wang P, Wu P, Egan RW, Billah MM: Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants. Gene 2003, 314:15-27.
31. Huai Q, Wang H, Zhang W, Colman RW, Robinson H, Ke H: Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc Natl Acad Sci U S A 2004, 101(26):9624-9629.
32. Wada I, Rindress D, Cameron PH, Ou WJ, Doherty JJ 2nd, Louvard D, Bell AW, Dignard D, Thomas DY, Bergeron JJ: SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J Biol Chem 1991, 266(29):19599-19610.
33. Linstedt AD, Hauri HP: Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 1993, 4(7):679-693.
34. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(259):680-685.